The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy (vol 32, 440, 2015)

被引:0
作者
Akman, Tulay [1 ]
Oztop, Ilhan [2 ]
Baskin, Yasemin [3 ]
Akbarpour, Mahdi [3 ]
Unal, Olcun Umit [4 ]
Oflazoglu, Utku [2 ]
Ellidokuz, Hulya [5 ]
Lebe, Banu [6 ]
机构
[1] Tepecik Training & Res Hosp, Dept Med Oncol, Izmir, Turkey
[2] Dokuz Eylul Univ, Fac Med, Dept Med Oncol, Izmir, Turkey
[3] Dokuz Eylul Univ, Inst Oncol, Dept Basic Oncol, Izmir, Turkey
[4] Ataturk Univ, Dept Med Oncol, Erzurum, Turkey
[5] Ataturk Univ, Dept Prevent Oncol, Inst Oncol, Erzurum, Turkey
[6] Ataturk Univ, Dept Pathol, Fac Med, Erzurum, Turkey
关键词
D O I
10.1007/s12032-015-0509-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 1 条
  • [1] The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy
    Akman, Tulay
    Oztop, Ilhan
    Baskin, Yasemin
    Akbarpour, Mahdi
    Unal, Olcun Umit
    Oflazoglu, Utku
    Ellidokuz, Hulya
    [J]. MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 10